Most states have taken a one-size-fits-all (or one-size-fits-most) approach to designing integrated care models for their ...

Current National Institutes of Health (NIH) policy allows corporations to commercialize medical technologies with few ...

The stable share of GDP devoted to health care reported in 2023 NHE data masks important underlying trends: Commercial prices ...

New Medicare standards have introduced changes that are intended to benefit dual-eligible individuals through increased ...

Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 percent, ...

Devices that are approved through a process that does not require any clinical evidence for FDA authorization should not ...

More than a dozen years after its enactment, policy and legal disputes related to the Affordable Care Act (ACA) remain. Various opponents have worked to overturn or chip away at the ACA since it ...

Attention must be paid to determining how extreme risk protection order laws can best be used with special populations such ...

CMS has aggressive 2030 goals to transform how care is provided by moving patients and providers toward accountable models of ...

A new analysis from the Office of the Actuary at the Centers for Medicare & Medicaid Services (CMS)—published online today by ...

In a new book review, Senior Editor Margaret Winchester reviews “Crowded Out: The True Costs of Crowdfunding Healthcare” by ...

Medicare drug price negotiation could have significant impacts on investment in post-approval studies for cancer treatment ...